Editorial: targeting aberrant hepatic inflammation for treatment of non-alcoholic steatohepatitis-authors' reply

Aliment Pharmacol Ther. 2022 Feb;55(4):485-486. doi: 10.1111/apt.16762.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Inflammation / drug therapy
  • Non-alcoholic Fatty Liver Disease* / drug therapy